ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 423,40
0,39%
Dow Jones
44 148,56
-0,22%
DAX
20 399,16
0,25%
Brent Oil
73,445
2,09%
Bitcoin
101 777,36
5,28%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Oncology Institute Inc (TOI)

  7. Oncology Institute Inc (TOI) Actualités

TOI

Oncology Institute (TOI)

Oncology Institute Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TOI
DateHeureSourceTitreSymboleSociété
13/11/202422h05GlobeNewswire Inc.The Oncology Institute Reports Third Quarter 2024 Financial ResultsNASDAQ:TOIOncology Institute Inc
11/11/202414h00GlobeNewswire Inc.The Oncology Institute Announces Certification to Administer Pluvicto Therapy in CaliforniaNASDAQ:TOIOncology Institute Inc
05/11/202401h09GlobeNewswire Inc.The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference CallNASDAQ:TOIOncology Institute Inc
23/10/202414h00GlobeNewswire Inc.The Oncology Institute Joins Lantern’s Cancer Care Network of ExcellenceNASDAQ:TOIOncology Institute Inc
14/10/202414h00GlobeNewswire Inc.The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer CareNASDAQ:TOIOncology Institute Inc
30/09/202414h00GlobeNewswire Inc.The Oncology Institute of Hope & Innovation Launches Oregon MarketNASDAQ:TOIOncology Institute Inc
23/09/202414h00GlobeNewswire Inc.The Oncology Institute Announces CFO TransitionNASDAQ:TOIOncology Institute Inc
13/08/202422h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TOIOncology Institute Inc
13/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TOIOncology Institute Inc
13/08/202422h05GlobeNewswire Inc.The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 GuidanceNASDAQ:TOIOncology Institute Inc
13/08/202411h45IH Market NewsU.S. Futures Climb Before Inflation Data; Oil Slips on OPEC Demand CutNASDAQ:TOIOncology Institute Inc
23/07/202414h00GlobeNewswire Inc.The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference CallNASDAQ:TOIOncology Institute Inc
29/05/202414h00GlobeNewswire Inc.The Oncology Institute to Participate at Upcoming Investor ConferencesNASDAQ:TOIOncology Institute Inc
22/05/202414h00GlobeNewswire Inc.The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring ConferenceNASDAQ:TOIOncology Institute Inc
14/05/202422h05GlobeNewswire Inc.The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 GuidanceNASDAQ:TOIOncology Institute Inc
07/05/202422h05GlobeNewswire Inc.The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation SummitNASDAQ:TOIOncology Institute Inc
23/04/202414h00GlobeNewswire Inc.The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference CallNASDAQ:TOIOncology Institute Inc
08/04/202414h00GlobeNewswire Inc.Jordan McInerney Appointed as Chief Development Officer of The Oncology InstituteNASDAQ:TOIOncology Institute Inc
04/04/202414h00GlobeNewswire Inc.The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern CaliforniaNASDAQ:TOIOncology Institute Inc
27/03/202421h05GlobeNewswire Inc.The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024NASDAQ:TOIOncology Institute Inc
14/03/202413h09GlobeNewswire Inc.MaxHealth & The Oncology Institute Expand Value-Based Care PartnershipNASDAQ:TOIOncology Institute Inc
06/03/202414h00GlobeNewswire Inc.The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference CallNASDAQ:TOIOncology Institute Inc
20/02/202414h00GlobeNewswire Inc.Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment ModelNASDAQ:TOIOncology Institute Inc
25/01/202414h00GlobeNewswire Inc.WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and OhioNASDAQ:TOIOncology Institute Inc
19/01/202422h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TOIOncology Institute Inc
28/12/202323h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TOIOncology Institute Inc
04/12/202314h00GlobeNewswire Inc.The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in CaliforniaNASDAQ:TOIOncology Institute Inc
08/11/202322h05GlobeNewswire Inc.The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 GuidanceNASDAQ:TOIOncology Institute Inc
18/10/202314h03GlobeNewswire Inc.The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference CallNASDAQ:TOIOncology Institute Inc
11/10/202322h05GlobeNewswire Inc.The Oncology Institute Names Jeremy Castle as Chief Operations OfficerNASDAQ:TOIOncology Institute Inc
 Showing the most relevant articles for your search:NASDAQ:TOI

Dernières Valeurs Consultées

NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
EU
AF
Air FranceKLM
COIN
ETHUSD
Ethereum
COIN
ADAUSD
Cardano
COIN
DOGEUSD
Dogecoin
EU
VK
Vallourec
EU
BN
Danone
EU
CS
Axa
EU
PX1
CAC 40
COIN
AVAXUSD
Avalanche
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés